Search

Your search keyword '"Barisic, Nina"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Barisic, Nina" Remove constraint Author: "Barisic, Nina"
144 results on '"Barisic, Nina"'

Search Results

1. De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke

2. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

4. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

5. Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability (P5-4.003)

6. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

7. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

8. High association of MOG-IgG antibodies in children with bilateral optic neuritis

9. De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies

10. Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.

12. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

13. 255 SUNFISH part 2: risdiplam in type 2 and type 3 SMA

14. Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease

15. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

16. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia

17. Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly

19. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

20. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

21. Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study.

23. genetic diagnosis; limb-girdle weakness; neuromuscular disease; next-generation sequencing; targeted exome analysisweakness

24. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome

26. Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene

27. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

28. SUNFISH Part 2: Efficacy and Safety of Risdiplam (RG7916) in Patients with Type 2 or Non-Ambulant Type 3 Spinal Muscular Atrophy (SMA) (1260)

29. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies

30. Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish

33. Significance of GPIbα -5T>C, GPIbα VNTR, GPVI T13254C polymorphisms and HPA-2 in the etiology of pediatric arterial ischemic stroke

34. High Association of MOG-IgG Antibodies in Children with Bilateral Optic Neuritis

35. A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy

36. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy

37. The phenotypic spectrum of SCN8A encephalopathy

38. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data

39. Erratum : De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies (American Journal of Human Genetics (2014) 95(4) (360–370)(S0002929714003838)(10.1016/j.ajhg.2014.08.013))

40. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data

41. Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disorders.

43. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data

44. De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies.

45. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data

46. Erratum: De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies (American Journal of Human Genetics (2014) 95(4) (360–370)(S0002929714003838)(10.1016/j.ajhg.2014.08.013))

47. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies

48. Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features

49. De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies

50. Najčešća neurološka kazuistika u pedijatrijskoj praksi - razine zbrinjavanja i smjernice u pedijatrijskoj neurologiji

Catalog

Books, media, physical & digital resources